Increasing Mirtazapine from 7.5 mg to 15 mg Will Likely Worsen Fatigue, Not Improve It
No, increasing mirtazapine from 7.5 mg to 15 mg will likely worsen your fatigue rather than help it. This counterintuitive dosing paradox occurs because mirtazapine's sedating antihistamine (H1) effects are most pronounced at lower doses, while higher doses engage more noradrenergic activity that can offset sedation 1, 2.
The Dose-Dependent Sedation Paradox
Mirtazapine exhibits an inverted U-curve for sedation:
- At 7.5 mg: Maximum H1 antihistamine blockade causes pronounced sedation and daytime sleepiness
- At 15-45 mg: Increased noradrenergic activity partially counteracts H1 effects, reducing (though not eliminating) sedation 2
The FDA-approved starting dose is 15 mg, not 7.5 mg, specifically because the lower dose produces more sedation 1. Research confirms that 7.5 mg causes no driving impairment but significant subjective somnolence, while 15 mg impairs driving performance—suggesting different mechanisms of sedation at each dose 3.
Evidence for Fatigue Improvement at Higher Doses
A 2011 study demonstrated that mirtazapine treatment (at therapeutic doses, not sub-therapeutic) significantly improved both daytime sleepiness and fatigue in depressed patients, with improvements measured on multiple validated scales (MSLT, ESS, SSS, FIS, FAF) 4. However, this benefit occurred when treating depression at proper therapeutic doses (15-45 mg), not at the sub-therapeutic 7.5 mg dose.
Most recent evidence (2025) specifically identifies bupropion—not mirtazapine—as superior for treating hypersomnia, increased appetite, and fatigue in depression 5. Conversely, mirtazapine excels at treating insomnia and decreased appetite 5.
Clinical Algorithm for Your Situation
If your primary complaint is fatigue:
- Discontinue mirtazapine entirely rather than increasing it—even at 15 mg, fatigue remains a common adverse effect 6
- Switch to bupropion, which has the strongest evidence for improving fatigue, hypersomnia, and increased appetite in depression 5
- If switching isn't feasible, increase to the FDA-recommended 15 mg minimum and wait 1-2 weeks to assess 1—but expect only partial improvement in fatigue
If your primary complaint is insomnia or poor sleep:
Critical Caveats
- 7.5 mg is sub-therapeutic for depression—the FDA label explicitly states 15 mg is the starting dose 1
- Dose changes require 1-2 weeks for evaluation 1
- About 63% of patients on second-generation antidepressants experience fatigue as an adverse effect 6
- Women and elderly patients have 18-27% higher mirtazapine blood levels at the same dose, increasing sedation risk 7
The evidence strongly suggests that if fatigue is your concern, you need a different medication strategy entirely, not a dose increase of mirtazapine.